Hematology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Podcasts Q&As
Interactive
Polls Quizzes
Events & Education
ASH Annual Meeting

FDA Alerts

FDA Approval
FDA sign
FDA Approval
FDA Approves Orforglipron (Foundayo) for Chronic Weight Management
04/02/2026
Anthony Calabro, MA
The FDA approved oral GLP-1 orforglipron (Foundayo) for weight management without food or water restrictions.
04/02/2026
FDA Approval
FDA sign
FDA Approval
FDA Approves Orforglipron (Foundayo) for Chronic Weight Management
04/02/2026
Anthony Calabro, MA
The FDA approved oral GLP-1 orforglipron (Foundayo) for weight management without food or water restrictions.
04/02/2026
FDA Approval
FDA sign
FDA Approval
FDA Approves Orforglipron (Foundayo) for Chronic Weight Management
04/02/2026
Anthony Calabro, MA
The FDA approved oral GLP-1 orforglipron (Foundayo) for weight management without food or water restrictions.
04/02/2026
FDA Approval
phone that says FDA
FDA Approval
FDA Approves Awiqli (Insulin Icodec-Abae) as Once-Weekly Basal Insulin for Adults With Type 2 Diabetes
03/27/2026
Anthony Calabro, MA
The FDA has approved insulin icodec-abae as the first once-weekly basal insulin option for glycemic control in adults with type 2 diabetes.
03/27/2026
FDA Approval
phone that says FDA
FDA Approval
FDA Approves Awiqli (Insulin Icodec-Abae) as Once-Weekly Basal Insulin for Adults With Type 2 Diabetes
03/27/2026
Anthony Calabro, MA
The FDA has approved insulin icodec-abae as the first once-weekly basal insulin option for glycemic control in adults with type 2 diabetes.
03/27/2026
FDA Approval
phone that says FDA
FDA Approval
FDA Approves Awiqli (Insulin Icodec-Abae) as Once-Weekly Basal Insulin for Adults With Type 2 Diabetes
03/27/2026
Anthony Calabro, MA
The FDA has approved insulin icodec-abae as the first once-weekly basal insulin option for glycemic control in adults with type 2 diabetes.
03/27/2026
FDA Approval
phone that says FDA
FDA Approval
FDA Approves Awiqli (Insulin Icodec-Abae) as Once-Weekly Basal Insulin for Adults With Type 2 Diabetes
03/27/2026
Anthony Calabro, MA
The FDA has approved insulin icodec-abae as the first once-weekly basal insulin option for glycemic control in adults with type 2 diabetes.
03/27/2026
FDA Approval
phone that says FDA
FDA Approval
FDA Approves Awiqli (Insulin Icodec-Abae) as Once-Weekly Basal Insulin for Adults With Type 2 Diabetes
03/27/2026
Anthony Calabro, MA
The FDA has approved insulin icodec-abae as the first once-weekly basal insulin option for glycemic control in adults with type 2 diabetes.
03/27/2026
FDA Approval
phone that says FDA
FDA Approval
FDA Approves Awiqli (Insulin Icodec-Abae) as Once-Weekly Basal Insulin for Adults With Type 2 Diabetes
03/27/2026
Anthony Calabro, MA
The FDA has approved insulin icodec-abae as the first once-weekly basal insulin option for glycemic control in adults with type 2 diabetes.
03/27/2026
FDA ALERT
Brain image
FDA ALERT
FDA Approves Avlayah (Tividenofusp Alfa-Eknm) for Neurologic Manifestations of Hunter Syndrome in Pediatric Patients
03/26/2026
Ashton L. Stahl
The FDA has approved Avlayah (tividenofusp alfa-eknm) for certain pediatric patients with Hunter syndrome, marking the first approval targeting the disease's neurologic complications and offering clinicians...
03/26/2026